Literature DB >> 30277395

Identification and Characterization of DNA Aptamers Specific for Phosphorylation Epitopes of Tau Protein.

I-Ting Teng1, Xiaowei Li1, Hamad Ahmad Yadikar2, Zhihui Yang2, Long Li1, Yifan Lyu3, Xiaoshu Pan1, Kevin K Wang2,4, Weihong Tan1,3.   

Abstract

Tau proteins are proteins that stabilize microtubules, but their hyperphosphorylation can result in the formation of protein aggregates and, over time, neurodegeneration. This phenomenon, termed tauopathy, is pathologically involved in several neurodegenerative disorders. DNA aptamers are single-stranded oligonucleotides capable of specific binding to target molecules. Using tau epitopes predisposed for phosphorylation, we identified six distinct aptamers that bind to tau at two phosphorylatable epitopes (Thr-231 and Ser-202) and to full-length Tau441 proteins with nanomolar affinity. In addition, several of these aptamers also inhibit tau phosphorylation (IT4, IT5, IT6) and tau oligomerization (IT3, IT4, IT5, IT6). This is the first report to identify tau epitope-specific aptamers. Such tau aptamers can be used to detect tau in biofluids and uncover the mechanism of tauopathy. They can be further developed into novel therapeutic agents in mitigating tauopathy-associated neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30277395      PMCID: PMC6442731          DOI: 10.1021/jacs.8b08645

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  36 in total

1.  Alzheimer's disease. The tangled tale of tau.

Authors:  E Mandelkow
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

2.  Rapid and Label-Free Strategy to Isolate Aptamers for Metal Ions.

Authors:  Hao Qu; Andrew T Csordas; Jinpeng Wang; Seung Soo Oh; Michael S Eisenstein; Hyongsok Tom Soh
Journal:  ACS Nano       Date:  2016-07-11       Impact factor: 15.881

3.  Neurotrophic protein S100 beta stimulates glial cell proliferation.

Authors:  R H Selinfreund; S W Barger; W J Pledger; L J Van Eldik
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 4.  FDA-Approved Oligonucleotide Therapies in 2017.

Authors:  Cy A Stein; Daniela Castanotto
Journal:  Mol Ther       Date:  2017-03-31       Impact factor: 11.454

Review 5.  Tau domains, phosphorylation, and interactions with microtubules.

Authors:  E M Mandelkow; J Biernat; G Drewes; N Gustke; B Trinczek; E Mandelkow
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

6.  In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits.

Authors:  L C Griffin; G F Tidmarsh; L C Bock; J J Toole; L L Leung
Journal:  Blood       Date:  1993-06-15       Impact factor: 22.113

7.  Modified DNA aptamer that binds the (R)-isomer of a thalidomide derivative with high enantioselectivity.

Authors:  Atsushi Shoji; Masayasu Kuwahara; Hiroaki Ozaki; Hiroaki Sawai
Journal:  J Am Chem Soc       Date:  2007-02-07       Impact factor: 15.419

8.  Single-stranded DNA aptamers specific for antibiotics tetracyclines.

Authors:  Javed H Niazi; Su Jin Lee; Man Bock Gu
Journal:  Bioorg Med Chem       Date:  2008-06-24       Impact factor: 3.641

Review 9.  Tau-based therapies in neurodegeneration: opportunities and challenges.

Authors:  Chuanzhou Li; Jürgen Götz
Journal:  Nat Rev Drug Discov       Date:  2017-10-06       Impact factor: 84.694

Review 10.  Cell-based Models To Investigate Tau Aggregation.

Authors:  Sungsu Lim; Md Mamunul Haque; Dohee Kim; Dong Jin Kim; Yun Kyung Kim
Journal:  Comput Struct Biotechnol J       Date:  2014-10-02       Impact factor: 7.271

View more
  10 in total

1.  Portable electrochemical micro-workstation platform for simultaneous detection of multiple Alzheimer's disease biomarkers.

Authors:  Yibiao Liu; Zhen Huang; Qing Xu; Lingyan Zhang; Qiong Liu; Tailin Xu
Journal:  Mikrochim Acta       Date:  2022-02-07       Impact factor: 5.833

2.  Point-of-Care Biosensor-Based Diagnosis of COVID-19 Holds Promise to Combat Current and Future Pandemics.

Authors:  Arpana Parihar; Pushpesh Ranjan; Sunil K Sanghi; Avanish K Srivastava; Raju Khan
Journal:  ACS Appl Bio Mater       Date:  2020-10-15

3.  Improving Sensitivity and Specificity of Amyloid-β Peptides and Tau Protein Detection with Antibiofouling Magnetic Nanoparticles for Liquid Biopsy of Alzheimer's Disease.

Authors:  Yuancheng Li; Esther Lim; Travis Fields; Hui Wu; Yaolin Xu; Y Andrew Wang; Hui Mao
Journal:  ACS Biomater Sci Eng       Date:  2019-06-10

4.  Structure-guided post-SELEX optimization of an ochratoxin A aptamer.

Authors:  Guohua Xu; Jiajing Zhao; Na Liu; Minghui Yang; Qiang Zhao; Conggang Li; Maili Liu
Journal:  Nucleic Acids Res       Date:  2019-06-20       Impact factor: 16.971

Review 5.  Proteomics technologies for cancer liquid biopsies.

Authors:  Zhiyong Ding; Nan Wang; Ning Ji; Zhe-Sheng Chen
Journal:  Mol Cancer       Date:  2022-02-15       Impact factor: 27.401

6.  Portable Vertical Graphene@Au-Based Electrochemical Aptasensing Platform for Point-of-Care Testing of Tau Protein in the Blood.

Authors:  Yibiao Liu; Xingyun Liu; Mifang Li; Qiong Liu; Tailin Xu
Journal:  Biosensors (Basel)       Date:  2022-07-25

7.  One Solution for All: Searching for Universal Aptamers for Constantly Mutating Spike Proteins of SARS-CoV-2.

Authors:  Jiuxing Li; Zijie Zhang; Ryan Amini; Yingfu Li
Journal:  ChemMedChem       Date:  2022-05-31       Impact factor: 3.540

Review 8.  Preparation, applications, and challenges of functional DNA nanomaterials.

Authors:  Lei Zhang; Mengge Chu; Cailing Ji; Jie Tan; Quan Yuan
Journal:  Nano Res       Date:  2022-08-31       Impact factor: 10.269

9.  Fluorescent Aptasensor and Colorimetric Aptablot for p-tau231 Detection: Toward Early Diagnosis of Alzheimer's Disease.

Authors:  Le Minh Tu Phan; Sungbo Cho
Journal:  Biomedicines       Date:  2022-01-01

Review 10.  Aptamer Applications in Neuroscience.

Authors:  Meric Ozturk; Marit Nilsen-Hamilton; Muslum Ilgu
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.